I
Integrity Applications Inc
NASDAQ:GCTK
Integrity Applications Inc
NASDAQ:GCTK
Price:
0.6828
USD
-17.75%
Market Closed
Market Cap:
$689.6k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Integrity Applications Inc
NASDAQ:GCTK
|
IL |
|
X
|
Xiamen Voke Mold & Plastic Engineering Co Ltd
SZSE:301196
|
CN |
|
King Slide Works Co Ltd
TWSE:2059
|
TW |
|
Kainos Group PLC
LSE:KNOS
|
UK |
|
Huaneng Lancang River Hydropower Inc
SSE:600025
|
CN |
|
Inabata & Co Ltd
TSE:8098
|
JP |
|
Lotte Chemical Titan Tbk PT
IDX:FPNI
|
ID |
|
D
|
Dios Exploration Inc
OTC:DIOSF
|
CA |
|
Sunworks Inc
OTC:SUNWQ
|
US |
|
E
|
Everlast Minerals Ltd
ASX:EV8
|
AU |
|
M
|
Mondi PLC
F:KYC
|
UK |
|
Goliath Film and Media Holdings
OTC:GFMH
|
US |
|
N
|
Ningbo Heli Technology Co Ltd
SSE:603917
|
CN |
|
B
|
Bioter SA
ATHEX:BIOT
|
GR |
|
C
|
Concrete Leveling Systems Inc
OTC:CLEV
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of GCTK.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GCTK
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
GCTK Competitors Multiples
Integrity Applications Inc Competitors
Integrity Applications Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
I
|
Integrity Applications Inc
NASDAQ:GCTK
|
689.6k USD | 0 | -0 | 0.2 | 0.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.8B USD | 4 | 27.1 | 15.5 | 21.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.8B USD | 16 | 56.3 | 42.6 | 52.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127B USD | 5.1 | 39.1 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.9B USD | 3.1 | 24 | 13.3 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
91.7B USD | 4.6 | 31.7 | 18.8 | 25.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.9B USD | 7.7 | 43.7 | 24 | 26.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.5B EUR | 1.8 | 20.2 | 11.3 | 15.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.8B USD | 10.6 | 43.3 | 30.7 | 33.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.1B USD | 2 | 25.1 | 10 | 16.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
